BACKGROUND: Bladder cancer accounts for over 150,000 deaths worldwide. No screening is available, so diagnosis depends on investigations of symptoms. Of these, only visible haematuria has been studied in primary care. AIM: To identify and quantify the features of bladder cancer in primary care. DESIGN AND SETTING: Case-control study, using electronic medical records from UK primary care. METHOD: Participants were 4915 patients aged ≥40 years, diagnosed with bladder cancer January 2000 to December 2009, and 21,718 age, sex, and practice-matched controls, were selected from the General Practice Research Database, UK. All clinical features independently associated with bladder cancer using conditional logistic regression were identified, and t...
Bladder and kidney cancer are the 10th and 7th most common cancers in the United Kingdom (UK). They ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
BACKGROUND: Bladder cancer accounts for over 150,000 deaths worldwide. No screening is available, so...
Access to the final published version is available via the NCBI link in this record.BACKGROUND: Diag...
This is the final version of the article. Available from Royal College of General Practitioners via ...
BACKGROUND: The diagnostic value and the impact of some signs and symptoms in most diseases in prima...
Funder: Action Bladder Cancer UKFunder: Rosetrees Trust; Id: http://dx.doi.org/10.13039/501100000833...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Several point‐of‐care urine tests have been developed to help identify patients who may be at higher...
Bladder and kidney cancer are the 10th and 7th most common cancers in the United Kingdom (UK). They ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
BACKGROUND: Bladder cancer accounts for over 150,000 deaths worldwide. No screening is available, so...
Access to the final published version is available via the NCBI link in this record.BACKGROUND: Diag...
This is the final version of the article. Available from Royal College of General Practitioners via ...
BACKGROUND: The diagnostic value and the impact of some signs and symptoms in most diseases in prima...
Funder: Action Bladder Cancer UKFunder: Rosetrees Trust; Id: http://dx.doi.org/10.13039/501100000833...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
OBJECTIVE: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tr...
Several point‐of‐care urine tests have been developed to help identify patients who may be at higher...
Bladder and kidney cancer are the 10th and 7th most common cancers in the United Kingdom (UK). They ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...
OBJECTIVE To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper ...